A

time-honored tradition in business media is searching through companies’ annual reports to see just how much they pay their treasured CEOs. As of this year, thanks to a provision in the Dodd-Frank law, it’s also possible to learn the median pay among employees at these companies.

In biopharma, that pay is pretty ample.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Is the ratio of CEO to median pay a real indication of effective CEO pay or more of a issue with the median pay to all employees (i.e. Geron lowest CEO to Employee ratio 5.4 X versus Geron with the highest median pay/employee of $500K. What would the chart look like if a broader assumption was made and a targeted median pay was used at X ( propose – $100k) level for large Pharma vs Y (propose $200K) for small/mid cap company (assuming median pay is higher to balancersik of working with a smaller company)

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.